All
Results: 34477-34488 of 38674

Silence Therapeutics Announces Positive Topline Results from Phase 1 Multiple Dose Study of Zerlasiran in Subjects with High Lipoprotein(a) and Stable Atherosclerotic Cardiovascular Disease

Onyx CenterSource Announces GroupPay Product Integration and Partnership with Cvent, to Launch in Late 2023
